Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elvio G Russi

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Oral Oncology|April 9, 2026
Randomizing treatment is not equivalent to validating biomarker-guided intensification in high-risk nasopharyngeal carcinomaElvio G Russi
Oral Oncology|April 2, 2026
Historical benchmarking should not be conflated with formal non-inferiority in the sequential Quarterback trialsElvio G Russi
European Urology Oncology|February 12, 2026
Re: Riccardo Bertoloa, Antonio Luigi Pastore, Paolo Verze, et al. Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2026.01.005Elvio G Russi
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 18, 2006
Consideration about axillary nodes and arm positionStefano Pergolizzi, Elvio G Russi
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2025
When predictions don't match reality: Revisiting sample size and PFS in the OpRAH studyElisa D'Angelo, Elvio G Russi
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 31, 2009
Epidermal growth factor receptor-inhibitors and radiotherapy-induced cutaneous adverse effects: "Koebner-Phenomenon" or radio-dermatitis?Marco C Merlano, Elvio G Russi
European Urology Oncology|March 21, 2026
Methodological Considerations on Causal Interpretability of the IRRADIaTE RegistryAlessio Bruni, Giacomo Ferrantelli, Elvio G Russi
International Journal of Radiation Oncology, Biology, Physics|March 1, 2011
Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634)Elvio G Russi, Gianmauro Numico, Umberto Ricardi
Current Treatment Options in Oncology|September 26, 2013
Strategies for non-resectable head and neck cancerNerina Denaro, Elvio G Russi, Marco C Merlano
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
Use of different urethrogram protocols can influence the definition of planning target volume inferior margin in prostate cancer radiotherapy. In regard to Liu et al.: prostate movement during simulation resulting from retrograde urethrogram compared with "natural" prostate movement (INT J RADIAT ONCOL BIOL PHYS 2004;60:470-475)Elvio G Russi, Riccardo Vigna Taglianti, Claudia Airaldi
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Oral Oncology|April 9, 2026
Randomizing treatment is not equivalent to validating biomarker-guided intensification in high-risk nasopharyngeal carcinomaElvio G Russi
Oral Oncology|April 2, 2026
Historical benchmarking should not be conflated with formal non-inferiority in the sequential Quarterback trialsElvio G Russi
European Urology Oncology|February 12, 2026
Re: Riccardo Bertoloa, Antonio Luigi Pastore, Paolo Verze, et al. Real-World Burden and Management of Late Genitourinary Toxicity After Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-Associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2026.01.005Elvio G Russi
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 18, 2006
Consideration about axillary nodes and arm positionStefano Pergolizzi, Elvio G Russi
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 8, 2025
When predictions don't match reality: Revisiting sample size and PFS in the OpRAH studyElisa D'Angelo, Elvio G Russi
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 31, 2009
Epidermal growth factor receptor-inhibitors and radiotherapy-induced cutaneous adverse effects: "Koebner-Phenomenon" or radio-dermatitis?Marco C Merlano, Elvio G Russi
European Urology Oncology|March 21, 2026
Methodological Considerations on Causal Interpretability of the IRRADIaTE RegistryAlessio Bruni, Giacomo Ferrantelli, Elvio G Russi
International Journal of Radiation Oncology, Biology, Physics|March 1, 2011
Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634)Elvio G Russi, Gianmauro Numico, Umberto Ricardi
Current Treatment Options in Oncology|September 26, 2013
Strategies for non-resectable head and neck cancerNerina Denaro, Elvio G Russi, Marco C Merlano
International Journal of Radiation Oncology, Biology, Physics|March 9, 2005
Use of different urethrogram protocols can influence the definition of planning target volume inferior margin in prostate cancer radiotherapy. In regard to Liu et al.: prostate movement during simulation resulting from retrograde urethrogram compared with "natural" prostate movement (INT J RADIAT ONCOL BIOL PHYS 2004;60:470-475)Elvio G Russi, Riccardo Vigna Taglianti, Claudia Airaldi
Pageof 5